Education
About Us
Working with TipRanks
Follow Us
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
NewAmsterdam Pharma Company (NAMS) Ownership Overview
16.25% Insiders
4.23% Mutual Funds
63.79% Other Institutional Investors
0.76% ETFs
14.97% Public Companies and
Individual Investors
The ownership structure of NewAmsterdam Pharma Company (NAMS) stock is a mix of institutional, retail, and individual investors. Approximately 68.78% of the company’s stock is owned by Institutional Investors, 16.25% is owned by Insiders, and 14.97% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 28, 2025 | James Topper Director | xxxxxxxxxxxxx | $25515 |
| Mar 06, 2025 | James Topper Director | xxxxxxxxxxxxx | $84185 |
| Mar 05, 2025 | xxxxxxxxxxxxx | $3055500 | |
| Oct 01, 2024 | xxxxxxxxxxxxx | $707400 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $767684 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $7327995 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $8198300 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $8995128 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,656,172 | Insider | 9.70% | 249,034,740 | |
| 8,845,000 | Institution | 8.05% | 206,707,650 | |
| 6,978,534 | Institution | 6.35% | 163,088,340 | |
| 6,813,434 | Insider | 6.20% | 159,229,953 | |
| 4,314,340 | Institution | 3.93% | 100,826,126 | |
| 2,976,076 | Institution | 2.71% | 69,550,896 | |
| 2,430,782 | Institution | 2.21% | 56,807,375 | |
| 715,474 | Institution | 0.65% | 16,720,627 | |
| 489,125 | Institution | 0.45% | 11,430,851 | |
| 415,891 | Institution | 0.38% | 9,719,373 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,976,076 | Institution | 2.71% | 69,550,896 | |
| 715,474 | Institution | 0.65% | 16,720,627 | |
| 489,125 | Institution | 0.45% | 11,430,851 | |
| 115,421 | Institution | 0.11% | 2,697,389 | |
| 100,391 | Institution | 0.09% | 2,346,138 | |
| 80,436 | Institution | 0.07% | 1,879,789 | |
| 53,744 | Institution | 0.05% | 1,255,997 | |
| 51,976 | Institution | 0.05% | 1,214,679 | |
| 44,539 | Institution | 0.04% | 1,040,876 | |
| 9,300 | Institution | <0.01% | 217,341 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 307,303 | Institution | 0.28% | 7,181,671 | |
| 113,281 | Institution | 0.10% | 2,647,377 | |
| 70,518 | Institution | 0.06% | 1,648,006 | |
| 65,538 | Institution | 0.06% | 1,531,623 | |
| 45,914 | Institution | 0.04% | 1,073,010 | |
| 45,591 | Institution | 0.04% | 1,075,036 | |
| 33,890 | Institution | 0.03% | 755,408 | |
| 29,008 | Institution | 0.03% | 684,009 | |
| 23,207 | Institution | 0.02% | 547,221 | |
| 16,425 | Institution | 0.01% | 387,302 |
FAQ
Who Owns NewAmsterdam Pharma Company (NAMS)?
According to the latest TipRanks data, approximately 63.79% of the company's stock is held by institutional investors, 16.25% is held by insiders, and 14.97% is held by retail investors.
What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 63.79% of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors.
What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.97% of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors.
Who owns the most shares of NewAmsterdam Pharma Company (NAMS)?
ForGrowth NAP B.V. owns the most shares of NewAmsterdam Pharma Company (NAMS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.